Table 2. Pyrosequencing results, with median methylation of normal tissue shown at bottom.
SLIT2 pyrosequencing of MSP site | Long range SLIT2 | |||||||
Sample | Tissue type | Location | CpG1 | CpG2 | CpG3 | CpG4 | CpG5 | Average methylation |
Serrated adenomas | SSA/P | Caecum | 22% | 70% * | 35% * | 51% * | 26% * | 10% |
SSA/P | Rectum | 35% * | 61% * | 48% * | 48% * | 0% | 0% | |
TSA | Caecum | 33% * | 33% | 29% | 0% | 21% * | 9% | |
SSA/P | Rectum | 36% * | 64% * | 49% * | 84% * | 0% | 0% | |
100% methylated | Human control DNA | - | 83% * | 88% * | 82% * | 94% * | 91% * | 85% |
Caecal polyp | Adenoma with low grade dysplasia | Caecum | 19% | 22% | 15% | 23% | 14% | - |
Normal mucosa | Normal mucosa | Ascending colon | 29% * | 36% * | 17% | 38% | 18% | - |
Normal mucosa | Transverse colon | 9% | 15% | 11% | 14% | 10% | - | |
Normal mucosa | Left colon | 16% | 29% | 0% | 32% | 17% | - | |
Normal mucosa | Descending colon | 16% | 17% | 20% | 26% | 9% | - | |
Normal mucosa | Sigmoid | 11% | 14% | 10% | 13% | 9% | - | |
Normal mucosa | Rectum | 14% | 14% | 13% | 17% | 8% | - | |
Normal mucosa | Distal rectum | 11% | 19% | 18% | 36% | 13% | - | |
Cell lines | C80 | - | 100% * | 91% * | 93% * | 100% * | 67% * | - |
HDC57 | - | 93% * | 69% * | 67% * | 97% * | 66% * | - | |
LOVO | - | 79% * | 90% * | 90% * | 100% * | 71% * | - | |
C99 | - | 95% * | 90% * | 88% * | 100% * | 74% * | - | |
LS123 | - | 100% * | 87% * | 94% * | 100% * | 56% * | - | |
CACO2 | - | 96% * | 91% * | 94% * | 100% * | 68% * | - | |
HDC82 | - | 84% * | 80% * | 92% * | 100% * | 67% * | - | |
COLO741 | - | 46% * | 52% * | 67% * | 73% * | 46% * | - | |
LS411 | - | 40% * | 38% * | 36% * | 42% | 23% * | - | |
CCK81 | - | 87% * | 90% * | 92% * | 100% * | 70% * | - | |
SNU175 | - | 64% * | 60% * | 80% * | 96% * | 64% * | - | |
Median | Normal tissue | 16% | 19% | 15% | 25% | 13% | - | |
SD | Normal tissue | 6% | 8% | 6% | 9% | 4% | - | |
2SD+median | Normal tissue | 28% | 34% | 30% | 43% | 20% |
Asterisks indicate hypermethylation (>2SD from median).